METTL1 and hepatocellular carcinoma: The findings indicated that METTL1-mediated m7G-tRNA modification can upregulate the translation of DNA-dependent protein kinase (DNA-PKcS) catalytic subunits or DNA ligase IV and promote double-strand break repair through the non-homologous end-joining pathway, leading to HCC radiotherapy resistance [24,25].